SAHA SAURABH

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$754,912.40
Insider Sells Quantity
11
Insider Sells Sum
$6.05M

Insider Activity of SAHA SAURABH

According to the SEC Form 4 filings, SAHA SAURABH, being in a position of

  1. Chief Executive Officer at Centessa Pharmaceuticals plc,
    оver the last 12 months, has bought 0 shares, and sold 372023 shares for $5.93M,
    over all time since 2021-11-16, has bought 76000 shares for $754,912, and sold 372023 shares for $5.93M.

The largest purchase of all time was on 2021-11-16 and amounted to 46000 shares of Centessa Pharmaceuticals plc for $564,944.

The largest sale of all time was on 2024-09-10 and amounted to 175000 shares of Centessa Pharmaceuticals plc for $2.89M.

Biography of SAHA SAURABH

No biography is available at this moment.

2024-11-13SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
32,023
0.0284%
$18.28$585,419-9.46%
2024-10-23SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
2,592
0.0023%
$15.32$39,6970%
2024-10-22SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
30,203
0.027%
$15.67$473,1690%
2024-10-21SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
22,205
0.0196%
$15.80$350,861+1.33%
2024-09-20SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
55,000
0.0484%
$16.53$908,985-3.56%
2024-09-10SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
175,000
0.1752%
$16.52$2.89M+9.67%
2024-08-30SaleClarivate Plc
CLVT
director
17,646
0.0024%
$6.75$119,111-3.21%
2024-08-23SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
46,651
0.0395%
$12.30$573,905+23.35%
2024-08-22SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
506
0.0004%
$12.23$6,188+29.75%
2024-08-21SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
3,674
0.0033%
$12.25$44,989+29.48%
2024-08-20SaleCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
4,169
0.0038%
$12.32$51,368+31.45%
2022-06-24PurchaseCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
20,000
0.0214%
$4.63$92,568-13.15%
2022-02-02PurchaseCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
10,000
0.0113%
$9.74$97,400-54.6%
2021-11-16PurchaseCentessa Pharmaceuticals plc
CNTA
Chief Executive Officer
46,000
0.0479%
$12.28$564,944-56.9%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.